Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist
- PMID: 32295786
- PMCID: PMC7359879
- DOI: 10.1136/annrheumdis-2020-217480
Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist
Keywords: antirheumatic agents; health services research; hydroxychloroquine.
Conflict of interest statement
Competing interests: FB reports personal fees from Boehringer, Bone Therapeutics, Expanscience, Galapagos, Gilead, GSK, Merck Sereno, MSD, Nordic, Novartis, Pfizer, Regulaxis, Roche, Sandoz, Sanofi, Servier, UCB, Peptinov, TRB Chemedica and 4P Pharma. RG reports personal fees from Pfizer, Cornerstones, Jannsen and Novartis. PK reports personal fees from GlaxoSmithKline, Sanofi-Aventis, Pfizer, Abbvie, Novartis Pharma, Eli Lilly and Bristol-Myers Squibb. AHJK reports grants from NIH (National Institutes of Health)/NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) and Rheumatology Research Foundation and personal fees from Exagen Diagnostics and GlaxoSmithKline. JAS reports grants from NIH/NIAID (National Institute of Allergy and Infectious Diseases)/Autoimmune Centers of Excellence, the Rheumatology Research Foundation, the Brigham Research Institute and the R. Bruce and Joan M. Mickey Research Scholar Fund as well as personal fees from Bristol-Myers Squibb, Gilead, Inova, Janssen and Optum.
Comment in
-
Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?Ann Rheum Dis. 2021 Mar;80(3):e29. doi: 10.1136/annrheumdis-2020-217828. Epub 2020 May 18. Ann Rheum Dis. 2021. PMID: 32424028 No abstract available.
-
Response to: 'Case series of acute arthritis in COVID-19 admission' by López-González et al.Ann Rheum Dis. 2021 Apr;80(4):e59. doi: 10.1136/annrheumdis-2020-217989. Epub 2020 May 29. Ann Rheum Dis. 2021. PMID: 32471896 No abstract available.
-
Case series of acute arthritis during COVID-19 admission.Ann Rheum Dis. 2021 Apr;80(4):e58. doi: 10.1136/annrheumdis-2020-217914. Epub 2020 May 29. Ann Rheum Dis. 2021. PMID: 32471899 No abstract available.
-
Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?Ann Rheum Dis. 2022 Aug;81(8):e154. doi: 10.1136/annrheumdis-2020-218259. Epub 2020 Jul 9. Ann Rheum Dis. 2022. PMID: 32647029 No abstract available.
-
Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Moreno et al.Ann Rheum Dis. 2022 Aug;81(8):e155. doi: 10.1136/annrheumdis-2020-218432. Epub 2020 Jul 9. Ann Rheum Dis. 2022. PMID: 32647030 No abstract available.
Comment on
-
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.Travel Med Infect Dis. 2020 Mar-Apr;34:101663. doi: 10.1016/j.tmaid.2020.101663. Epub 2020 Apr 11. Travel Med Infect Dis. 2020. PMID: 32289548 Free PMC article.
References
-
- Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html. (accessed 31 March 2020).
-
- Request for Emergency Use Authorization For Use of Chloroquine Phosphate or Hydroxychloroquine Sulfate Supplied From the Strategic National Stockpile for Treatment of 2019 Coronavirus Disease. https://www.fda.gov/media/136534/download. (accessed 30 March 2020).
-
- Advisory on the use of hydroxychloroquine as prophylaxis for SARS-CoV-2 infection. https://www.mohfw.gov.in/pdf/AdvisoryontheuseofHydroxychloroquinasprophy.... (accessed 31 March 2020).
-
- Décret n° 2020–314 du 25 mars 2020 complétant le décret n° 2020–293 du 23 mars 2020 prescrivant les mesures générales nécessaires pour faire face à l’épidémie de covid-19 dans le cadre de l’état d’urgence sanitaire. https://www.legifrance.gouv.fr/eli/decret/2020/3/25/SSAZ2008362D/jo/texte. (accessed 30 March 2020).
-
- Texas State Board of Pharmacy. https://www.pharmacy.texas.gov/files_pdf/291.30.pdf. (accessed 30 March 2020).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources